http://orcid.org/0000-0001-7973-7184
Citations (29)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Rebecca Orr, David Skvarc, Catherine Emerson, Lauren Beswick, Lisa Olive, Sarah David & Antonina Mikocka-Walus. (2022) Patients with inflammatory bowel disease at risk of sub-optimal outcomes report poorer biopsychosocial functioning than controls: data from two cross-sectional surveys. Psychology, Health & Medicine 0:0, pages 1-16.
Read now
Read now
Hakan Parlakpinar & Mehmet Gunata. (2021) Transplantation and immunosuppression: a review of novel transplant-related immunosuppressant drugs. Immunopharmacology and Immunotoxicology 43:6, pages 651-665.
Read now
Read now
Articles from other publishers (27)
Koon Jiew Chua, Hua Ling, In Young Hwang, Hui Ling Lee, John C. March, Yung Seng Lee & Matthew Wook Chang. (2022)
An Engineered Probiotic Produces a Type III Interferon IFNL1 and Reduces Inflammations in
in vitro
Inflammatory Bowel Disease Models
. ACS Biomaterials Science & Engineering 9:9, pages 5123-5135.
Crossref
Crossref
Muhammad Ali Muzammil, FNU Fariha, Tirath Patel, Rohab Sohail, Munesh Kumar, Ejaz Khan, Bushra Khanam, Satesh Kumar, Mahima Khatri, Giustino Varrassi & Prasanthi Vanga. (2023) Advancements in Inflammatory Bowel Disease: A Narrative Review of Diagnostics, Management, Epidemiology, Prevalence, Patient Outcomes, Quality of Life, and Clinical Presentation. Cureus.
Crossref
Crossref
Xinge Xu, Jingwei Wu, Yuxin Jin, Kunlun Huang, Yuanyuan Zhang & Zhihong Liang. (2023) Both Saccharomyces boulardii and Its Postbiotics Alleviate Dextran Sulfate Sodium-Induced Colitis in Mice, Association with Modulating Inflammation and Intestinal Microbiota. Nutrients 15:6, pages 1484.
Crossref
Crossref
Heike E. F. Becker, Karlijn Demers, Luc J. J. Derijks, Daisy M. A. E. Jonkers & John Penders. (2023) Current evidence and clinical relevance of drug-microbiota interactions in inflammatory bowel disease. Frontiers in Microbiology 14.
Crossref
Crossref
Qianyu Li, Siyu Zhou, Yanna Wang & Jing Cong. (2022) Changes of intestinal microbiota and microbiota-based treatments in IBD. Archives of Microbiology 204:7.
Crossref
Crossref
Bei Li, Haibo Zhang, Linlin Shi, Rong Li, Yanan Luo, Yun Deng, Shihan Li, Ruizhen Li & Zhi Liu. (2022)
Saccharomyces boulardii
alleviates DSS-induced intestinal barrier dysfunction and inflammation in humanized mice
. Food & Function 13:1, pages 102-112.
Crossref
Crossref
Shahrbanoo Jahangir, Sareh Zeydabadinejad, Zhila Izadi, Mahdi Habibi-Anbouhi & Ensiyeh Hajizadeh-Saffar. 2022. Translational Autoimmunity. Translational Autoimmunity
319
359
.
Elleni J Pippis & Bruce R Yacyshyn. (2021) Clinical and Mechanistic Characteristics of Current JAK Inhibitors in IBD. Inflammatory Bowel Diseases 27:10, pages 1674-1683.
Crossref
Crossref
Menghang Zu, Ya Ma, Brandon Cannup, Dengchao Xie, Yunjin Jung, Jinming Zhang, Chunhua Yang, Fei Gao, Didier Merlin & Bo Xiao. (2021) Oral delivery of natural active small molecules by polymeric nanoparticles for the treatment of inflammatory bowel diseases. Advanced Drug Delivery Reviews 176, pages 113887.
Crossref
Crossref
Daniele Maria-Ferreira, Jorge Luiz Dallazen, Claudia Rita Corso, Adamara Machado Nascimento, Thales Ricardo Cipriani, Paulo da Silva Watanabe, Debora de Mello Gonçales Sant'Ana, Cristiane Hatsuko Baggio & Maria Fernanda de Paula Werner. (2021) Rhamnogalacturonan polysaccharide inhibits inflammation and oxidative stress and alleviates visceral pain. Journal of Functional Foods 82, pages 104483.
Crossref
Crossref
Yan Jiang, Li Zhao, Qing Chen & Lihong Zhou. (2021) Exploring the Mechanism of Berberine Intervention in Ulcerative Colitis from the Perspective of Inflammation and Immunity Based on Systemic Pharmacology. Evidence-Based Complementary and Alternative Medicine 2021, pages 1-11.
Crossref
Crossref
Martina Franzin, Katja Stefančič, Marianna Lucafò, Giuliana Decorti & Gabriele Stocco. (2021) Microbiota and Drug Response in Inflammatory Bowel Disease. Pathogens 10:2, pages 211.
Crossref
Crossref
Flávia Danniele Frota Machado, Rodrigo de Oliveira Formiga, Gedson Rodrigues de Morais Lima, Neyres Zínia Taveira de Jesus, Edvaldo Balbino Alves Júnior, Alexsandro Fernandes Marinho, Josean Fechine Tavares, Flávia Almeida Santos, Ana Flávia Seraine Custódio Viana, Aurigena Antunes Araújo, Raimundo Fernandes de Araújo Júnior, Cláudia Helena Pellizzon & Leônia Maria Batista. (2021) Hyptis suaveolens (L.) Poit protects colon from TNBS-induced inflammation via immunomodulatory, antioxidant and anti-proliferative mechanisms. Journal of Ethnopharmacology 265, pages 113153.
Crossref
Crossref
Mario-Livio Jeličić, Edvin Brusač, Daniela Amidžić Klarić, Biljana Nigović, Nikša Turk & Ana Mornar. (2020) A chromatographic approach to development of 5-aminosalicylate/folic acid fixed-dose combinations for treatment of Crohn’s disease and ulcerative colitis. Scientific Reports 10:1.
Crossref
Crossref
Lei Tu, Payam Gharibani, Jieyun Yin & Jiande D. Z. Chen. (2020) Sacral nerve stimulation ameliorates colonic barrier functions in a rodent model of colitis. Neurogastroenterology & Motility 32:10.
Crossref
Crossref
Mariana Ferreira-Duarte, Joana Beatriz Sousa, Carmen Diniz, Teresa Sousa, Margarida Duarte-Araújo & Manuela Morato. (2020) Experimental and Clinical Evidence of Endothelial Dysfunction in Inflammatory Bowel Disease. Current Pharmaceutical Design 26:30, pages 3733-3747.
Crossref
Crossref
Yanzhi Wang, Rongrong Ren, Gang Sun, Lihua Peng, Yaping Tian & Yunsheng Yang. (2020) Pilot study of cytokine changes evaluation after fecal microbiota transplantation in patients with ulcerative colitis. International Immunopharmacology 85, pages 106661.
Crossref
Crossref
M. Plaza-Oliver, A. Beloqui, M.J. Santander-Ortega, L. Castro-Vázquez, V. Rodríguez-Robledo, M.M. Arroyo-Jiménez, V. Préat & M.V. Lozano. (2020) Ascorbyl-dipalmitate-stabilised nanoemulsions as a potential localised treatment of inflammatory bowel diseases. International Journal of Pharmaceutics 586, pages 119533.
Crossref
Crossref
Adrian Bartoszek, Adam Makaro, Agnieszka Bartoszek, Radzisław Kordek, Jakub Fichna & Maciej Salaga. (2020) Walnut Oil Alleviates Intestinal Inflammation and Restores Intestinal Barrier Function in Mice. Nutrients 12:5, pages 1302.
Crossref
Crossref
Anton S. Tkachenko, Galina I. Gubina-Vakulyck, Vladimir K. Klochkov, Nataliya S. Kavok, Anatolii I. Onishchenko, Tatyana V. Gorbach & Oksana A. Nakonechna. (2020) Experimental Evaluation of the Impact of Gadolinium Orthovanadate GdVO4:Eu3+ Nanoparticles on the Carrageenan-Induced Intestinal Inflammation. Acta Medica (Hradec Kralove, Czech Republic) 63:1, pages 18-24.
Crossref
Crossref
Cristina Gely, Laura Marín, Jordi Gordillo, Míriam Mañosa, Federico Bertoletti, Fiorella Cañete, Carlos González-Muñoza, Margalida Calafat, Eugeni Domènech & Esther Garcia-Planella. (2020) Impact of pain associated with the subcutaneous administration of adalimumab. Gastroenterología y Hepatología 43:1, pages 9-13.
Crossref
Crossref
Cristina Gely, Laura Marín, Jordi Gordillo, Míriam Mañosa, Federico Bertoletti, Fiorella Cañete, Carlos González-Muñoza, Margalida Calafat, Eugeni Domènech & Esther Garcia-Planella. (2020) Impact of pain associated with the subcutaneous administration of adalimumab. Gastroenterología y Hepatología (English Edition) 43:1, pages 9-13.
Crossref
Crossref
Yan Tian, Yan Zhou, Sisi Huang, Jun Li, Kui Zhao, Xiaohui Li, Xiangchen Wen & Xiao-an Li. (2019) Fecal microbiota transplantation for ulcerative colitis: a prospective clinical study. BMC Gastroenterology 19:1.
Crossref
Crossref
Triet M. BuiRonen Sumagin. (2019) Progressing from Recurring Tissue Injury to Genomic Instability: A New Mechanism of Neutrophil Pathogenesis. DNA and Cell Biology 38:8, pages 747-753.
Crossref
Crossref
Li-Na Dong, Mu Wang, Jian Guo & Jun-Ping Wang. (2019) Role of intestinal microbiota and metabolites in inflammatory bowel disease. Chinese Medical Journal 132:13, pages 1610-1614.
Crossref
Crossref
Renata Curciarello, Karina Eva Canziani, Guillermo Horacio Docena & Cecilia Isabel Muglia. (2019) Contribution of Non-immune Cells to Activation and Modulation of the Intestinal Inflammation. Frontiers in Immunology 10.
Crossref
Crossref
Carl Spana, Andrew W. Taylor, David G. Yee, Marie Makhlina, Wei Yang & John Dodd. (2019) Probing the Role of Melanocortin Type 1 Receptor Agonists in Diverse Immunological Diseases. Frontiers in Pharmacology 9.
Crossref
Crossref